The trial, Safety and Effectiveness of an Intracranial Aneurysm Embolization System for Treating Large or Giant Wide Neck Aneurysms (SCENT), will be looking at a new device used in the treatment of large and wide neck brain aneurysms.
“This clinical research study is designed to determine safety and effectiveness of the Surpass NeuroEndoGraft System (Surpass System), an investigational device developed to treat wide neck, large or giant intracranial aneurysms. An intracranial aneurysm is a bulge in the wall of a blood vessel in the brain. The bulge is caused by a weakening of the vessel wall. If left untreated, the bulge may continue to grow larger and ultimately the vessel may break open (rupture), resulting in serious bleeding into or around the brain. The information collected from this study will be used to evaluate how well patients do when treated with the Surpass System both immediately after treatment of an aneurysm and over a long period of time (5 years).”–clinicaltrials.gov
The trial is underway at approximately 20 centers nation-wide. The first two patients to be enrolled in the trial in New York City were recently treated by Dr. Meyers at Columbia University Medical Center.
You can learn more about this trial here
You have added pages to your clipboard. Please log in or create an account to share them or use later.
You are now being taken to Columbia Neurosurgery's site dedicated to the spine.
Use this button to save pages to your clipboard for future use.OK. Got it.